This Month’s Cover Story

Regulatory Rewind

A mix of the biggest hits from 2018

PM1912 WebLeadImage 295X269

In a year marked by rapid technological shifts and mounting political pressures to solve pharma-related policy issues, U.S. regulators have had their work cut out for them. But at the start of the year, the U.S. Food and Drug Administration’s commissioner, Scott Gottlieb, laid out a policy roadmap for the year that promised to tackle some of the country’s thorniest health troubles.By and large, the agency has delivered on its promises, crafting a range of new guidance documents and regulations that address critical pharma policy areas such as opioid addiction and prescription drug costs.But the important question is: What does all this mean for pharma…

Full Story

Don't Miss These Pharma Manufacturing Exclusives


On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Top 5 Drugs With the Biggest Growth Potential in 2019

    By Meagan Parrish, Senior Editor

    Although personalized medicines are on the rise, the era of blockbuster drugs is far from over. In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow. In December, Evaluate Pharma released its pharma industry…

    Full Story
  • Curing Batch Record Pain Points

    By Terrance Holbrook, Senior Product Manager, MasterControl

    Industry 4.0 and smart manufacturing are top of mind for manufacturing leaders and analysts alike. Associated with the cloud, big data, machine learning, the Industrial Internet of Things (IIoT) and predictive analytics, this new wave of connected digital technologies offers manufacturers…

    Full Story
  • The Shutdown and the FDA: What Pharma Companies Need to Know

    By Joel M. Wallace and Imron T. Aly, partners, Schiff Hardin

    As the government shutdown stretches on, pharmaceutical companies must manage the partial shutdown of the U.S. Food and Drug Administration (FDA). The longer the shutdown lasts, the more likely that FDA review of applications will be delayed, affecting company launch plans and business…

    Full Story
  • Best and Worst Places to Find STEM Jobs

    By staff

    According to the latest U.S. Bureau of Labor Statistics analysis, STEM — science, technology, engineering and math — professions grew at over twice the rate that non-STEM jobs did between 2009 and 2015.In the increasingly competitive global pharmaceutical environment, it is critical that the…

    Full Story
  • Top Pharma Manufacturing Predictions for 2019

    What will 2019 have in store for pharma manufacturers? From new tech to innovative business models and shifting regulations, industry experts weigh in on what changes are coming down the pipeline. Innovations in Manufacturing Automation continues its rise: The entire pharmaceutical industry is…

    Full Story
  • China's Biopharma Growth: Can it Continue?

    By Vicky (Qing) Xia, Senior Project Director, BioPlan Associates

    China is a relative newcomer to the biopharmaceutical industry. Biological therapeutics by multinational corporations in China have been on the market only since the 1990s,1 but the country has been making rapid and significant progress ever since.The sales of biopharmaceuticals in China’s market…

    Full Story

Latest Products